ERYtech Enters Into Research Agreement With MD Anderson Cancer Center
John Weinstein, principal investigator of the project, said: “L-ASP is a standard component of leukemia chemotherapy regimens, but it’s not used yet against solid tumors due to erratic
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.